Trial Profile
Evaluation of the influence of Vildagliptin on chorioretinal blood flow in patients with diabetic retinopathy
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 18 May 2016
Price :
$35
*
At a glance
- Drugs Vildagliptin (Primary) ; Antihyperglycaemics
- Indications Diabetic retinopathy; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 22 Jan 2013 New trial record